Clasificación en acciones
#39190
hVIVO plc (HVO) operates as a premier full-service Contract Research... hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.
Precio por acción
$0.08860889
Capitalización bursátil
$609.98K
Precio HVO con Capital del mercado a B
Capitalización de mercado de HVIVO plc(HVO)
Capitalización bursátil: $609.98K
A fecha de August 2026, HVIVO plc tiene una capitalización de mercado de $609.98K. Esto convierte a HVIVO plc en la 39190th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de HVIVO plc desde 2012 hasta 2026
HVO en comparación con los más populares 5 títulos stocks
| Precio por HVO |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.470T
|
+896,668,417.49%
|
|
|
|
|
$4.467T
|
+732,325,422.91%
|
|
|
|
|
$4.174T
|
+684,343,072.41%
|
|
|
|
|
$3.700T
|
+606,585,496.51%
|
|
|
|
|
$2.854T
|
+467,936,925.15%
|
